INTRODUCTION {#S2}
============

Circadian rhythms regulate the expression of up to 20% of all genes in the body, controlling diverse aspects of cell physiology and pathology, including cell proliferation, stem cell functions, and tissue regeneration ([@R24]; [@R33]; [@R39]). Mammalian circadian rhythms are organized by the suprachiasmatic nucleus (SCN) in the hypothalamus. Light stimulation received by the retina is transmitted to the SCN, which then synchronizes the circadian rhythms of body temperature, sleep/awake, and other physiological regulations through hormones and the autonomic nervous system. Disruption of the SCN causes desynchronization of circadian rhythms in the body, but the rhythms persist at a single-cell level because of the intrinsic and ubiquitous Clock/Bmal1 feedback system. This system allows isolated cells to autonomously maintain circadian rhythms *in vitro*.

At the core of circadian gene regulation lies the auto-regulatory loop centered on the Clock/Bmal1 transcription factor complex ([@R6]; [@R12]; [@R39]). The oscillating expression level of *Bmal1* generally reaches the highest level during light-on hours and the lowest level during light-off hours *in vivo*. The two basic-helix-loop-helix Per-Arnt-Sim (PAS) transcription factors Clock and Bmal1 form a hetero-dimer and activate target genes, including *Cry1*, *Cry2*, *Per1*, and *Per2*, through binding to the E-box (5′-CANNTG-3′) in their promoters. Cry and Per proteins then heterodimerize and inhibit the Clock/Bmal1 complex, forming the first negative feedback loop. Cry and Per proteins subsequently undergo phosphorylation and ubiquitination, leading to degradation by the proteasomal pathway. This degradation relieves Clock/Bmal1 from the negative feedback loop and restarts the next cycle of Clock/Bmal1-stimulated gene activation. Clock/Bmal1 also activates the transcription of genes encoding RORα (retinoic acid receptor-related orphan receptor α), RORβ, and RORγ as well as Rev-erbα (reverse orientation c-erbAα) and Rev-erbβ. RORs activate but Rev-erbs inhibit the transcription of *Bmal1* through competition for binding sites at the promoter of *Bmal1*, providing the second feedback loop of circadian rhythms. These feedback loops exist in almost all tissues examined.

Mouse Cry1 and Cry2 proteins contain 606 and 592 amino acids, respectively, and share 89.4% similarity at the amino acid level. *Cry1*^−/−^ and *Cry2*^−/−^mice are fertile without any gross morphological abnormalities and can sustain circadian rhythms ([@R41]; [@R42]). In contrast, *Cry1*^−/−^ *Cry2*^−/−^ double knockout (KO) mice completely lose the rhythms, indicating the presence of functional redundancy between the two genes. However, several findings indicate that Cry1 and Cry2 cannot completely compensate for each other. For example, although the circadian period of *Cry1*^−/−^ mice is around 23 hr, that of *Cry2*^−/−^ mice is around 25 hr ([@R40]; [@R41]). In addition, inactivation of *Cry2*, but not *Cry1*, can restore lost circadian rhythms in *Per2* partial deletion mutant mice ([@R31]). Furthermore, only Cry2 serves as a component of an E3 ligase complex that ubiquitinates c-Myc prior to its degradation ([@R13]). Specific molecular interactions underlying these differences remain largely elusive.

Circadian rhythms control the expression of genes encoding cell cycle regulators, including p21 (*Cdkn1a*), cyclin D1 (*Ccnd1*), and c-Myc ([@R38]). This oscillating expression controls circadian phase-specific cell proliferation in a tissue-specific manner. Although DNA replication reaches the maximum level in late afternoon in human keratinocytes ([@R10]), it reaches a peak in early morning in human rectal epithelial cells ([@R5]). Cell differentiation is also regulated by circadian rhythms in a tissue-specific manner ([@R15]). For example, knockdown (KD) of *Clock* or *Per2* inhibits differentiation of mesenchymal stem cells into adipocytes but not into osteoblasts ([@R3]). Epidermal stem cells express genes important for differentiation and organelle biogenesis in a circadian manner ([@R14]). Progression of hair follicle cycling is delayed by disruption of *Clock* or *Bmal1* in mice ([@R23]).

Adult skeletal muscle regeneration is mediated by myogenic stem cells, called satellite cells, which are mitotically quiescent in adult muscle ([@R30]). However, they initiate proliferation upon stimulation by weight bearing or through damage. The progenies of activated satellite cells, now called myoblasts, undergo multiple rounds of cell division prior to terminal differentiation. The cells that have exited from the cell cycle, called myocytes, form multinucleated myotubes by cell fusion. During maturation, myotubes continuously enlarge through additional myocyte fusion as well as increased cytoplasmic volume per nucleus, resulting in functional myofibers with the capability of contraction. Aging and various diseases impair the capacities of muscle regeneration, including satellite cell proliferation, self-renewal, and myogenic differentiation, resulting in dystrophic and atrophic muscle ([@R35]).

In mouse skeletal muscle, more than 2,000 genes are expressed in a circadian manner ([@R11]; [@R32]). The Clock/Bmal1 complex binds to the E-box in the core enhancer of the *MyoD* gene and induces circadian oscillation of *MyoD* expression ([@R1]; [@R22]). Deletion of the mouse *Clock* or *Bmal1* gene abolishes *MyoD* oscillation and disrupts myofilament architecture and contractile force. Consistent with this *MyoD* regulation, decreased expression of *Bmal1* disrupts the differentiation of myoblasts to myotubes, which can be explained by impaired Wnt signaling ([@R7]). Currently, virtually nothing is known about the specific contributions of Cry and Per to myogenic differentiation and muscle regeneration.

The present study focuses on the differential roles of Cry1 and Cry2 in the differentiation of mouse myoblasts to myotubes *in vitro* and muscle regeneration *in vivo*. This study unexpectedly uncovered that Cry2 promotes cell cycle exit of myoblasts and myocyte fusion during differentiation.

RESULTS {#S3}
=======

Opposing Effects of *Cry1* and *Cry2* KO on Muscle Regeneration {#S4}
---------------------------------------------------------------

Both *Cry1*^−/−^ and *Cry2*^−/−^ mice appeared healthy without any obvious skeletal muscle defects. To understand whether there were any differences in the capacity for muscle regeneration between these KO mice, we damaged the *tibialis anterior* (TA) muscle by intramuscular injection of barium chloride. We then examined regeneration with immunofluorescence staining of embryonic myosin heavy chain (eMHC), an early marker for regenerating myofibers, and H&E staining. This study revealed that *Cry1* KO accelerated, whereas *Cry2* KO delayed, muscle regeneration compared with wild-type (WT) TA muscle. Specifically, on day 3 after injection, *Cry1*^−/−^ TA muscle contained more regenerating myofibers expressing eMHC than WT TA muscle, whereas such myofibers were rare in *Cry2*^−/−^ TA muscle ([Figures 1A and 1B](#F1){ref-type="fig"}). On day 4, eMHC(+) myofibers were larger in *Cry1*^−/−^ and smaller in *Cry2*^−/−^ TA muscle relative to the WT ([Figure 1C](#F1){ref-type="fig"}). On day 5, eMHC became almost undetectable in WT and *Cry1*^−/−^ TA muscle but remained abundant in *Cry2*^−/−^ TA muscle ([Figure 1A](#F1){ref-type="fig"}). H&E staining of day 7 TA muscle showed that *Cry1*^−/−^ myofibers were larger but *Cry2*^−/−^ myofibers were smaller than their WT counterparts ([Figures 1D and 1E](#F1){ref-type="fig"}). Phenotypic differences between each strain were already evident in un-injected adult TA muscle. H&E staining showed that myofibers were slightly larger in *Cry1*^−/−^ TA muscle than in WT TA muscle. *Cry2*^−/−^ TA muscle followed a bimodal distribution, and the average size was smaller than WT TA muscle, except for a particularly large population ([Figures 1F and 1G](#F1){ref-type="fig"}). The causal meaning of the large population remains unknown. Furthermore, Sirius red staining revealed more abundant fibrosis in both KO mouse TA muscles, a sign of disrupted regeneration, than in WT muscles ([Figures 1H and 1I](#F1){ref-type="fig"}). These results uncovered opposing roles of Cry1 and Cry2: Cry1 as an inhibitor and Cry2 as a promoter of muscle regeneration. The increased fibrosis in *Cry1*^−/−^ TA muscles is an exception to this conclusion; it is possible that *Cry1* KO does more than accelerate muscle regeneration.

Primary myoblasts were isolated from mice to investigate whether these muscle phenotypes were cell-autonomous. More than 98% of the cells of each mouse strain expressed MyoD, validating successful purification ([Figures 2A and 2B](#F2){ref-type="fig"}). Even before induction of differentiation, the expression of sarcomeric MHC (a marker for differentiating myocytes) was higher in *Cry1*^−/−^ myoblasts and lower in *Cry2*^−/−^ myoblasts than in WT myoblasts ([Figure 2B](#F2){ref-type="fig"}). Upon induction of differentiation with 5% horse serum (HS), MHC was expressed only in 43% of *Cry2*^−/−^ myoblasts, in contrast with 63% in WT and 81% in *Cry1*^−/−^ cells on day 1 ([Figures 2A and 2C](#F2){ref-type="fig"}). Although MHC was activated in more than 95% of WT and *Cry1*^−/−^ myoblasts by day 2, *Cry2*^−/−^ myoblasts lagged behind ([Figure 2D](#F2){ref-type="fig"}). We also calculated the fusion index in each cell type by dividing the number of nuclei located within MHC(+) cells containing two or more nuclei by the total number of nuclei in a given field. The fusion index was higher in *Cry1*^−/−^ myoblasts and lower in *Cry2*^−/−^ myoblasts compared with WT myoblasts on differentiation day 3 ([Figure 2E](#F2){ref-type="fig"}). The differences in fusion efficiency were also highlighted by the \< 3 nuclei index, which was obtained by dividing the number of nuclei residing in MHC(+) cells that contained only one or two nuclei by the number of nuclei in all MHC(+) cells. The index was lower in *Cry1*^−/−^ myoblasts and higher in *Cry2*^−/−^ myoblasts compared with the WT ([Figure 2F](#F2){ref-type="fig"}). Furthermore, after single muscle fibers were isolated and cultured for 72 hr, the frequency MyoD(+)Pax7(−) differentiating myoblasts were higher with *Cry1*^−/−^ fibers and lower with *Cry2*^−/−^ fibers compared with WT fibers ([Figures S1A and S1B](#SD1){ref-type="supplementary-material"}). Thus, myogenic differentiation was cell-autonomously promoted in *Cry1*^−/−^ myoblasts but inhibited in *Cry2*^−/−^ myoblasts *in vitro*, recapitulating *in vivo* muscle regeneration.

*Cry1* KD Promotes but *Cry2* KD Inhibits Myoblast Differentiation In Vitro {#S5}
---------------------------------------------------------------------------

To understand the molecular mechanisms underlying the differential effects of *Cry1* and *Cry2* KO, we differentiated mouse myoblast C2C12 cells as a model after KD of the *Cry1* and *Cry2* genes. Two shRNA clones decreased each target mRNA level to lower than 20% of scrambled control short hairpin RNA (shRNA) ([Figure S1C](#SD1){ref-type="supplementary-material"}). The KD cells were induced for myogenic differentiation and stained with an MHC antibody. On days 3 and 5 of differentiation, MHC(+) cells were more dense with *Cry1* KD but more sparse and shorter with *Cry2* KD than the control ([Figure 3A](#F3){ref-type="fig"}). Consistently, the differentiation index, defined as the frequency of nuclei existing in MHC(+) cells among all nuclei, was higher in *Cry1* KD cells and lower in *Cry2* KD cells than in control cells on day 5 ([Figure 3B](#F3){ref-type="fig"}). A similar trend in the expression of MHC was observed at the mRNA level on day 5 ([Figure 3C](#F3){ref-type="fig"}). Additionally, *Cry1* KD upregulated three other markers for differentiation: myogenin, myomaker, and creatine kinase M (Ckm), compared with the control. The lower fusion index and the higher \< 3 nuclei index in *Cry2* KD cells ([Figures 3D and 3E](#F3){ref-type="fig"}) suggested that impaired cell fusion was an underlying mechanism for the short myotube phenotype. Overall, the KD experiments with C2C12 cells recapitulated the phenotypes observed with the primary myoblasts isolated from the KO mice.

The total number of nuclei in *Cry2* KD cells was less than 80% of control cells on differentiation day 5 ([Figure 3F](#F3){ref-type="fig"}). *Cry2* KD promoted cell cycle exit during differentiation, as shown by the more rapid decline of the uptake of 5-ethynyl-2′-deoxyuridine (EdU) compared withthe control and *Cry1*KD cells ([Figure 3G](#F3){ref-type="fig"}). However, before differentiation induction, all cell types proliferated at similar rates, as shown with an MTS assay (\[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazo-lium, inner salt\]) ([Figure S1D](#SD1){ref-type="supplementary-material"}). The lower cell density in the *Cry2* KD wells could be a reason for the inefficient cell fusion and the consequent short myotube phenotype; however, the differentiation index and fusion index remained lower and the \< 3 nuclei index was higher compared with control cells when 50% more cells were seeded before differentiation ([Figures S1E--S1G](#SD1){ref-type="supplementary-material"}). These results indicate that inefficient cell fusion with the *Cry*2 KD was not due to early exit from the cell cycle.

Differential Gene Expression by *Cry1* and *Cry2* KD {#S6}
----------------------------------------------------

We compared RNA sequencing (RNA-seq) data between each KD and control cell line on differentiation days 0, 3, and 5 to understand the mechanisms underlying the opposing roles of Cry1 and Cry2 in myogenic differentiation ([Figures S2A](#SD1){ref-type="supplementary-material"}). Genes that were expressed at \> 200% or \< 50% of the control level were selected for further analyses. More genes were differentially expressed between each KD compared with the number of genes that were up or downregulated in both KDs ([Figure 4A](#F4){ref-type="fig"}). Gene ontology (GO) analysis of the differentially expressed genes indicated that muscle-specific genes, including those indicative of differentiation (myogenin, myomaker \[also called Tmem8c\], MHC 1 and 3, and myosin light chain 1), were upregulated in *Cry1* KD cells compared with control and *Cry2* KD cells on day 0 ([Figures S2B and S2C](#SD1){ref-type="supplementary-material"}, highlighted in yellow). This suggested premature initiation of differentiation of *Cry1* KD cells; however, the difference disappeared on days 3 and 5. There was no GO term that could readily explain the delayed differentiation of *Cry2* KD cells.

However, further inspection of the RNA-seq data revealed that the expression level of *Ccnd1* (cyclin D1) was lower in *Cry2* KD cells than in the control and *Cry1* KD cells on day 3 ([Figure S2D](#SD1){ref-type="supplementary-material"}, arrow). In contrast, *Ccnd2* (cyclin D2) was not lower in *Cry2* KD cells compared with the other cells ([Figures S2D and S2E](#SD1){ref-type="supplementary-material"}). qPCR verified prominent downregulation of *Ccnd1* in *Cry2* KD cell lines established with two shRNA clones on days 1, 3, and 5 ([Figure 4B](#F4){ref-type="fig"}). *Ccnd1* is known to be downregulated upon initiation of myoblast differentiation, which leads to cell cycle exit ([@R43]). The premature downregulation of *Ccnd1* in *Cry2* KD cells could potentially explain the early cell cycle exit of *Cry2* KD cells, as studied below.

Early Cell Cycle Exit in *Cry2* KD Cells because of the Downregulation of Cyclin D1 {#S7}
-----------------------------------------------------------------------------------

*Ccnd1* expression is regulated by circadian rhythms in the liver ([@R9]; [@R38]), but the Cry2-specific contribution to *Ccnd1* expression has not been reported. To understand whether Cry2 regulates the circadian expression pattern of *Ccnd1 in vivo*, the mRNA levels of circadian regulators and *Ccnd1* in TA muscle were determined with qPCR every 4 hr for 44 hr. Consistent with a previous work ([@R1]) and the Circadian Expression Profiles Database (CircaDB; <http://circadb.hogeneschlab.org/>), *Bmal1*, *Per1*, *Cry1*, and *Cry2* were expressed in TA muscle in circadian manners, although there was variation in the peak timing of the same genes between each strain ([Figure 4C](#F4){ref-type="fig"}). *Cry1* and *Cry2* were not upregulated in *Cry2*^−/−^ TA muscle and *Cry1*^−/−^ TA muscle, respectively, indicating a lack of compensatory upregulation between the two genes. Importantly, although *Ccnd1* also showed circadian expression patterns in WT and *Cry1*^−/−^ TA muscle, the amplitude of the oscillation was substantially weakened in *Cry2*^−/−^ TA muscle, indicating Cry2-dependent circadian oscillation of the *Ccnd1* mRNA level in TA muscle.

Because TA muscle is a mixture of mitotically quiescent myofibers and many other types of proliferating cells, we turned to C2C12 cells to separately characterize the expression in proliferating C2C12 myoblasts and differentiating C2C12 cells that were undergoing cell cycle exit. In the first experiment with undifferentiated C2C12 cells, the circadian rhythms of the sparsely seeded cells were synchronized with forskolin between −1 and 0 hr, and the cells were harvested every 4 hr thereafter while they were proliferating. *Cry1* and *Cry2* levels showed typical circadian rhythms with around a 24-hr period in control cells, whereas their levels were consistently low in each KD cell line, verifying effective KD throughout the experiments ([Figure 4D](#F4){ref-type="fig"}). The *Ccnd1* level and EdU uptake also demonstrated circadian oscillation in all three cell types with similar amplitudes ([Figures 4D and 4E](#F4){ref-type="fig"}). The lack of *Ccnd1* downregulation in *Cry2* KD cells agreed with the PCR result of non-synchronized day 0 cells ([Figure 4B](#F4){ref-type="fig"}).

In the second experiment, circadian rhythms in confluent C2C12 cells were synchronized with forskolin between −1 and 0 hr, and differentiation was induced at 0 hr. *Cry1* and *Cry2* were expressed in a circadian manner during differentiation for 120 hr in control and *Cry1* KD cells ([Figure 4F](#F4){ref-type="fig"}). *Ccnd1* levels gradually decreased, with several transient upregulation peaks in these cells. However, the intermittent peaks were not observed with *Cry2* KD cells. Consistently, the circadian pattern of EdU uptake seen in the control and *Cry1* KD cells disappeared in *Cry2* KD cells ([Figure 4G](#F4){ref-type="fig"}). The numbers of total nuclei at 120 hr of differentiation were substantially lower in *Cry2* KD cells compared with control cells, reflecting the lost EdU uptake peaks ([Figure 4H](#F4){ref-type="fig"}). Together, these results demonstrate that *Ccnd1* mRNA was expressed in a circadian manner in both undifferentiated and differentiating cells and that its downregulation by *Cry2* KD became prominent only during differentiation.

Although previous results showed that a lower cell number was not the cause for the inefficient cell fusion in *Cry2* KD cells, we verified this point with *Ccnd1* KD cells. After KD of *Ccnd1* with two shRNAs ([Figure S3A](#SD1){ref-type="supplementary-material"}), cells were induced to differentiate ([Figure S3B](#SD1){ref-type="supplementary-material"}). Nuclear numbers on day 5 were lower with the KD cells than with control cells, as expected ([Figure S3C](#SD1){ref-type="supplementary-material"}). We did not find statistically significant differences in differentiation index, fusion index, or \< 3 index between control and *Ccnd1* KD cells ([Figures S3D--S3F](#SD1){ref-type="supplementary-material"}). Thus, downregulation of *Ccnd1* by *Cry2* KD cannot explain the inefficient cell fusion with the KD cells.

Inefficient Cell Fusion in *Cry2* KD Cells because of the Lack of Tmem176b {#S8}
--------------------------------------------------------------------------

We searched for additional candidate genes within the RNA-seq data to explain the inefficient cell fusion by *Cry2* KD. This identified the transmembrane protein gene *Tmem176b* as a promising candidate. First, its expression level was lower throughout differentiation in non-synchronized *Cry2* KD cells than in other cells, according to RNA-seq ([Figure S4A](#SD1){ref-type="supplementary-material"}, arrows) and qPCR ([Figure 5A](#F5){ref-type="fig"}). The expression level of *Tmem176b* showed circadian oscillation in TA muscle in WT and *Cry1*^−/−^ mice as well as in differentiating C2C12 cells after synchronization of the control and *Cry1* KD cells ([Figures 5B and 5C](#F5){ref-type="fig"}). However, the expression was downregulated with weakened circadian oscillation in *Cry2* KO TA muscle and KD cells. CircaDB also indicates that *Tmem176b* shows a circadian expression pattern in skeletal muscle. In addition, Tmem176b shares 67.4% similarity at the amino acid level with myomaker, one of the best characterized fusion inducers ([@R28]).

To examine whether Tmem176b is involved in myogenic differentiation, its KD cells were induced to differentiate ([Figures S4B](#SD1){ref-type="supplementary-material"} and [5D](#F5){ref-type="fig"}). *Tmem176b* KD cells showed lower differentiation indexes ([Figure 5E](#F5){ref-type="fig"}); the fusion indexes were also lower, and the \< 3 nuclei indexes were markedly increased by the KD ([Figures 5F and 5G](#F5){ref-type="fig"}). Next, the circadian pattern of myogenic cell fusion in synchronized cells was assessed by categorizing the cells based on the number of nuclei within MHC(+) myocytes/myotubes. In control cells, the percentage of nuclei in MHC(+) cells containing only one nucleus suddenly decreased, whereas the percentage of nuclei in MHC(+) cells containing two nuclei increased sharply between 64 to 68 hr ([Figure 5H](#F5){ref-type="fig"}, control, \*\*). This was followed by a drastic increase of those in MHC(+) cells containing more than 10 nuclei between 84 and 88 hr and between 108 and 112 hr. *Cry1* KD cells showed a similar pattern between 88 and 92 hr and between 108 and 112 hr. In contrast, these sudden increases of fused cells were not observed with *Cry2* KD or *Tmem176b* KD cells. These results strongly indicate that downregulation of *Tmem176b* by *Cry2* KD indeed prevented proper cell fusion during differentiation. As a side note, *Cry1* KD increased the frequency of nuclei in MHC(+) cells containing 3--5 nuclei compared with control cells ([Figure 5H](#F5){ref-type="fig"}, *Cry1* KD, green line), suggesting accelerated cell fusion. In a complementary study, overexpressed *Tmem176b* decreased the fusion index, but it was largely due to the lower differentiation index compared with control cells, as indicated by the similar values of the \< 3 nuclei index between control and overexpressing cells ([Figures S4C--S4G](#SD1){ref-type="supplementary-material"}).

Identification of Bclaf1 as a Cry2-Specific Binding Protein {#S9}
-----------------------------------------------------------

To understand how mRNA levels of *Ccnd1* and *Tmem176b* were regulated specifically by Cry2, Cry1- and Cry2-binding proteins were immunoprecipitated after overexpression of each FLAG-tagged protein in undifferentiated C2C12 cells ([Figure 6A](#F6){ref-type="fig"}). We detected three peptide fragments of Bclaf1 (Bcl-2 associated factor 1) specifically in the co-precipitated protein pool with Cry2 in addition to three circadian regulators: Per1, Fbxl3 (F-box type E3 ligase for Cry proteins), and CK1δ (phosphorylates Per proteins) ([@R12]) by high-resolution peptide tandem mass spectrometry and database searching after proteolytic digestion ([Figures S5A and S5B](#SD1){ref-type="supplementary-material"}). Cry2-specific interaction of Bclaf1 was verified by western blotting in the same immunoprecipitated protein pool ([Figure 6B](#F6){ref-type="fig"}). Reciprocal immunoprecipitation of endogenous proteins also confirmed the interaction on day 3 differentiating cells ([Figure 6C](#F6){ref-type="fig"}). *Bclaf1* is under circadian regulation in muscle ([@R1]), TA muscle ([Figure 6D](#F6){ref-type="fig"}, black line), and differentiating synchronized C2C12 cells ([Figure 6E](#F6){ref-type="fig"}, black line). The *Bclaf1* circadian rhythms were not disrupted by KO or KD of *Cry2* ([Figures 6D and 6E](#F6){ref-type="fig"}, red lines). Importantly, KD of *Bclaf1* ([Figure S5D](#SD1){ref-type="supplementary-material"}) decreased the circadian expression of *Ccnd1* and abolished the circadian uptake of EdU during differentiation ([Figures 6F and 6G](#F6){ref-type="fig"}). Consistently, the nuclear numbers were substantially lower with *Bclaf1* KD cells on day 5 ([Figure 6H](#F6){ref-type="fig"}). However, *Bclaf1* KD did not decrease the proliferation of the cells before induction of differentiation, which was similar to *Cry2* KD ([Figure S5E](#SD1){ref-type="supplementary-material"}). As for cell fusion, *Bclaf1* KD cells lost the circadian expression pattern of *Tmem176b* ([Figure 6I](#F6){ref-type="fig"}) and showed lower differentiation indexes and fusion indexes and higher \< 3 nuclei indexes than control cells ([Figures 6J--6M](#F6){ref-type="fig"}). In summary, *Bclaf1* KD recapitulated two phenotypes of *Cry2* KD, promoted cell cycle exit and inefficient cell fusion, indicating that Bclaf1 cooperatively functions with Cry2 in *Ccnd1* and *Tmem176b* gene regulation.

Bclaf1 Regulates the Stability of *Ccnd1* and *Tmem176b* mRNAs {#S10}
--------------------------------------------------------------

Previous work reported that Bclaf1 forms a protein complex that binds to and stabilizes *Ccnd1* mRNA, but not *Ccnd2*, in an osteosarcoma cell line ([@R4]). We tested whether *Tmem176b* mRNA co-precipitates with Bclaf1 after immunoprecipitation of Bclaf1 ([Figure 7A](#F7){ref-type="fig"}) from differentiation day 3 cells without shRNA. Indeed, *Ccnd1* and *Tmem176b* mRNAs were enriched in the precipitated RNA pool compared with two control genes: glyceraldehyde 3-phosphate dehydrogenase (*Gapdh*) and β-actin (*Actb*) ([Figure 7B](#F7){ref-type="fig"}). mRNA stability was then assessed by quantifying mRNA levels while new transcription was inhibited by actinomycin D in undifferentiated KD cells. *Ctla2a* mRNA, whose half-life is 687 min in C2C12 cells ([@R21]), was used as a stable control mRNA ([Figure S6A](#SD1){ref-type="supplementary-material"}). *Bclaf1* KD substantially decreased the half-life of *Tmem176b* (control versus KD = 8.5 hr versus 2.3--4.1 hr) and *Ccnd1* mRNAs (9.1 hr versus 3.6 hr) but not *Ccnd2* mRNA ([Figure 7C](#F7){ref-type="fig"}). Similarly, *Cry2* KD shortened the half-life of only *Tmem176b* and *Ccnd1* mRNAs ([Figure 7D](#F7){ref-type="fig"}). This finding agrees with decreased binding of the mRNAs to Bclaf1 in *Cry2* KD cells ([Figure 7E](#F7){ref-type="fig"}). In contrast, *Cry1* KD did not affect mRNA binding or mRNA stability ([Figures S6B--S6D](#SD1){ref-type="supplementary-material"}).

The levels of nascent mRNAs encoding *Ccnd1*, *Ccnd2*, and *Tmem176b* were not decreased by KD of *Bclaf1*, *Cry1*, or *Cry2* ([Figure S7A](#SD1){ref-type="supplementary-material"}), indicating that mRNA stability, rather than transcription, was disrupted by *Bclaf1* and *Cry2* KD. In addition, *Cry1* KD did not rescue the *Bclaf1* KD phenotypes ([Figure S7B--S7F](#SD1){ref-type="supplementary-material"}), which demonstrates that Cry1's promoted myoblast differentiation was independent of Bclaf1. This is in line with the results showing that *Cry1/2* double KD phenocopied *Cry2* KD ([Figure S7G--S7K](#SD1){ref-type="supplementary-material"}). Taken together, the cooperative stabilization of *Ccnd1* and *Tmem176b* mRNAs by Cry2 and Bclaf1 provides a mechanistic explanation for the significance of Bclaf1 in promoting circadian myoblast proliferation and myogenic fusion.

DISCUSSION {#S11}
==========

This study uncovered circadian regulation of myogenic differentiation through mRNA stabilization. The following working model summarizes our findings. In undifferentiated and proliferating myoblasts, *Ccnd1* is abundantly expressed, and its downregulation by instability because of the depletion of the Cry2-Bclaf1 complex is not evident, which allows cells to sustain a normal proliferation level. However, when differentiation begins and *Ccnd1* is transcriptionally downregulated, instability of the mRNAs by Cry2-Bclaf1 depletion becomes prominent, resulting in accelerated cell cycle exit. As for cell fusion, *Tmem176b* is continuously expressed regardless of the differentiation status; it is necessary to promote cell fusion when differentiation is initiated. Collectively, the coordinated circadian oscillation of the expression levels of *Cry2*, *Bclaf1*, *Ccnd1*, and *Tmem176b* leads to circadian myoblasts proliferation and cell fusion during differentiation. However, it remains unknown whether there is any advantage for the circadian regulation of these processes. Another important question would be whether embryonic myoblast differentiation is also regulated by circadian rhythms. Unlike adult muscle regeneration, embryonic muscle differentiation takes place as a highly coordinated series of events in a spatial and temporal manner. Nonetheless, it is possible that maternal hormones and metabolism regulated by circadian rhythms add another layer to the regulation of the cell cycle and other events in embryonic development, including myogenesis.

In other model systems, circadian rhythms regulate gene activity at various post-transcriptional levels, including alternative splicing, polyadenylation, and mRNA nuclear export ([@R2]; [@R34]). Such post-transcriptional regulation appears to be highly prevalent in circadian genes. A recent nascent RNA sequencing (nascent-seq) study showed that 70% of oscillating mRNAs in the liver demonstrate poor oscillation at the transcriptional level ([@R27]). However, previous works on the circadian regulation of myogenesis were primarily concerned with transcriptional activation of *MyoD* by Clock/Bmal1 ([@R1]; [@R7]; [@R22]). Because Crys are supposed to inhibit Clock/Bmal1, they are expected to delay myogenesis, which Cry1 appears to achieve. In contrast, Cry2 plays an opposite role through post-transcriptional regulation. In this sense, Cry1 can be regarded as "classic" Cry, whereas Cry2 would be "deviated" Cry. The *Drosophila* genome encodes only one *cry* gene, which shares around 75% similarity with both mouse Crys at the amino acid level. Functional and structural comparison between mouse and *Drosophila* Crys could shed further light on the division of labor between mouse Cry1 and Cry2.

Another way to dissect the structural mechanism underlying the Cry2-specific interaction with Bclaf1 would be to create hybrid proteins between Cry1 and Cry2 as reported by [@R17]. They divided each protein into four domains and created a series of hybrid proteins swapping each domain. From this work, they found that the helical domain in the middle of the protein is necessary for the Cry1-specific circadian rhythm regulation in fibroblasts. Combined with mutagenesis at the amino acid level and a 3D structural model, they identified several amino acids exposed to the surface that are critical for regulation. The same domain swapping was also used to determine the Cry2-specific interaction with nuclear hormone receptors ([@R20]).

Bclalf1 was originally identified as a pro-apoptotic binding partner of the adenovirus protein E1B 19K ([@R16]; [@R36]). Bclaf1 was later found to be widely expressed and to play additional roles, such as transcriptional regulation and mRNA stabilization. A majority of *Bclaf1*^−/−^ mice die within 2 days after birth because of major defects in lung development ([@R26]). Bclaf1 contains an arginine/serine (RS) domain that mediates protein-protein interactions and is typically detected in proteins involved in mRNA processing ([@R37]). In our study, individual KD of *Cry2* and *Bclaf1* both lead to destabilization of bound mRNAs. A similar cooperative stabilization of bound mRNAs by multiple protein subunits has been reported with another Bclaf1 complex called the SNIP1/SkIP-associated RNA-processing complex ([@R4]). Among the five subunits in the complex, three subunits, including Bclaf1, are necessary to maintain the expression level of *Ccnd1*. Our mass spectrometry did not detect other protein components in the complex; this could be due to technical differences or a cell type difference.

Tmem176b belongs to the MS4A membrane protein family, which is characterized by four transmembrane domains (tetra-spanin) and is involved in membrane signaling, such as calcium influx in B cells ([@R44]). *Tmem176b* is ubiquitously expressed, but the most prominent phenotypes of *Tmem176b*^−/−^ mice are disorganized cerebellar development and severe ataxia ([@R25]). Currently, muscle abnormalities of *Tmem176b*^−/−^ mice have not been reported. Tmem176b is distantly related to myomaker, which is essential for cell fusion ([@R28]). Unlike Tmem176b, myomaker contains seven transmembrane domains and does not belong to the MS4A family. However, Tmem176b and myomaker share 67.4% similarity within the 129 amino acids in the amino terminus of Tmem176b and the carboxyl terminus of myomaker, which contains a necessary region for its fusogenic function ([@R29]). Overexpression of Tmem176b did not promote cell fusion, which is similar to the result from the overexpression of myomaker ([@R28]). This could be because interacting proteins also need to be overexpressed to promote cell fusion, given the complex process of membrane fusion during myogenesis ([@R8]; [@R18]). Additionally, the expression level of *Tmem176b* did not increase during differentiation in control C2C12 cells ([Figure 5A](#F5){ref-type="fig"}). These results indicate that, although Tmem176b is necessary for efficient cell fusion, it is not a limiting factor that defines the pace of the fusion. In addition to inhibited cell fusion, *Tmem176b* KD decreased differentiation index ([Figure 5E](#F5){ref-type="fig"}), suggesting that it is involved in additional differentiation programs, potentially through a membrane signaling mechanism. This possibility needs further study.

The differential roles between Cry1 and Cry2 suggest that Per1 and Per2 might also play distinct roles in myogenic differentiation. A chromatin immunoprecipitation sequencing (ChIP-seq) analysis indicated that the six core circadian regulators (Clock, Bmal1, Cry1/2, and Per1/2) have hundreds of chromatin binding sites unique to each of them, in addition to 1,444 common binding sites ([@R19]). The current approach of using synchronized myoblasts would provide a powerful *in vitro* model to investigate the unique functions of each regulator, which would, in turn, shed light onto mechanisms underlying circadian rhythm-regulated myogenic differentiation and muscle regeneration.

EXPERIMENTAL PROCEDURES {#S12}
=======================

KO Mice {#S13}
-------

All protocols were approved by the Institutional Animal Care and Usage Committee of the University of Minnesota (1602-33471A and 1604-33660A). *Cry1^+/−^* mice (B6.129P2-Cry1*^tm1Asn^*/J, stock number 016186) and *Cry2^+/−^* mice (B6.129P2-Cry2*^tm1Asn^*/J, stock number 016185) were purchased from Jackson Laboratory. Two to four mice of mixed genders at the age of 6 to 12 weeks were used unless specified otherwise. Age-matched littermate WT mice were used as controls. We injected 50 μL 1.2% BaCl~2~ in 0.9% NaCl into the left TA muscle of four WT, *Cry1*^−/−^, and *Cry2*^−/−^ mice. Cryosections with a thickness of 10 μm were prepared for immunofluorescence, H&E, and Sirius red staining.

Circadian Gene Expression in TA Muscles {#S14}
---------------------------------------

WT, *Cry1*^−/−^, and *Cry2*^−/−^ male mice were entrained at 12-hr light and 12-hr dark cycles (6 a.m. to 6 p.m. light and 6 p.m. to 6 a.m. dark) for 2 weeks before experiments. This means that zeitgeber time 0 (ZT0) corresponds to 6 a.m. and ZT12 to 6 p.m. TA muscles were isolated every 4 hr starting at ZT2.

Synchronization of Circadian Rhythms of Undifferentiated and Proliferating C2C12 Cells {#S15}
--------------------------------------------------------------------------------------

C2C12 cells were seeded on day −1. On day 1, 10 μM forskolin was added between −1 and 0 hr. Cells were washed with PBS twice, and fresh 10% fetal bovine serum (FBS) in DMEM was added at 0 hr. Cells were harvested for PCR or fixed for immunofluorescence staining every 4 hr for 44 hr. Cells were also pulse-labeled with 0.5 μM EdU for 30 min at each time point.

Synchronization of Circadian Rhythms of Differentiating C2C12 Cells {#S16}
-------------------------------------------------------------------

C2C12 cells were seeded on day −2. On day 0, forskolin was added between −1 and 0 hr. Cells were washed with PBS, and differentiation was started at 0 hr. Cells were harvested for PCR, fixed for immunofluorescence staining, or treated with EdU every 4 hr for 120 hr.

Statistical Analysis {#S17}
--------------------

Student's t test was used in the analysis of statistical significance of the difference in qRT-PCR data. The mean + SD obtained from three independent tests is shown in each graph. A chi-square test was used to determine the statistical significance of the difference in the histograms of muscle regeneration in [Figure 1](#F1){ref-type="fig"}. The test was applied to the heart of the histogram, where the raw expected values were more than 5 cells per bin, with the WT as the expected value and the *Cry1*^−/−^ or *Cry2*^−/−^ as the actual values.
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![Regeneration of TA Muscle in *Cry1*^−/−^ and *Cry2*^−/−^ Mice\
(A) Immunofluorescence staining of TA muscle with eMHC antibody on days 3, 4, and 5 after injection with barium chloride. Laminin staining defines the border of each myofiber. DNA was counterstained with Hoechst 33342. TA muscles were damaged and harvested between 10 a.m. and 2 p.m. (zeitgeber time 4 \[ZT4\] and ZT8), when *Cry1* and *Cry2* mRNA levels were low ([Figure 4C](#F4){ref-type="fig"}). This was because the peak timing of these mRNA levels was variable among WT, *Cry1*^−/−^, and *Cry2*^−/−^ mice, leaving the lower expression level timing more consistent.\
(B) The frequency of myofibers with eMHC staining in a ring shape in regenerating myofibers, identified by ring-shaped laminin staining on day 3. In undamaged myofibers, eMHC was not expressed, and laminin staining displayed polygonal shapes. eMHC staining was defined as a ring shape with an unstained area in the center, corresponding to a centrally located nucleus, with a diameter larger than 10 μm. Muscle areas of 5 mm^2^ were observed in each mouse, and two mice were used for each strain.\
(C) Size distribution of eMHC(+) myofiber cross-sections on day 4. We measured 2,000 myofibers from two mice, totaling 4,000 myofibers for each strain. Chi-square analysis indicates that *Cry1*^−/−^ myofibers were larger and that *Cry2*^−/−^ myofibers were smaller than those of the WT, with p \< 0.01. Average sizes of myofiber cross-section areas are as follows: WT, 66.2 μm^2^; *Cry1*^−/−^ 68.4 μm^2^; and *Cry2*^−/−^ 55.7 μm^2^.\
(D) H&E staining of day 7 TA sections.\
(E) Size distribution of the H&E-stained myofiber cross-sections on day 7. 500 randomly selected myofibers from four mice, totaling 2,000 myofibers for each mouse strain, were measured. Chi-square analysis indicates that *Cry1*^−/−^ myofibers were larger and that *Cry2*^−/−^ myofibers were smaller than WT myofibers, with p \< 0.01. Average sizes of myofiber cross-section areas are as follows: WT, 1,111.7 μm^2^; *Cry1*^−/−^ 1,136.4 μm^2^; and *Cry2*^−/−^, 1,018.2 μm^2^.\
(F) H&E staining of uninjected TA sections. Unusually large myofibers are marked with asterisks.\
(G) Size distribution of the cross-sections of uninjected myofibers. Two thousand myofibers for each mouse strain were measured as described in (E). *Cry1*^−/−^ myofibers were larger than WT myofibers, with p \< 0.01 from Chi-square analysis. Average sizes of myofibers are as follows: WT, 1,580.4 μm^2^; *Cry1*^−/−^, 1,815.0 μm^2^; and *Cry2*^−/−^, 1,789.6 μm^2^.\
(H) Sirius red staining of uninjected TA muscles isolated from 10-week-old mice.\
(I) Area percentage of fibrosis, indicated by positive Sirius red staining in (H).\
\*p \< 0.05 and \*\*p \< 0.01 with Student's t test. Data are presented as mean + SD in (B) and (I). Scale bars, 100 μm.](nihms947898f1){#F1}

![Differentiation of *Cry1*^−/−^ and *Cry2*^−/−^ Myoblasts\
(A) Immunostaining of primary myoblasts prepared from WT, *Cry1*^−/−^, and *Cry2*^−/−^ mice with antibodies against MHC and MyoD. Cells were induced to differentiate with 5% HS for 1 and 3 days. Scale bar, 50 μm.\
(B--D) Frequency of nuclei within MyoD(+) or MHC(+) cells among 500 total nuclei on day 0 (B), day 1 (C), and day 2 (D).\
(E and F) Fusion index (E) and \< 3 nuclei index (F) on day 2, based on observation of 500 nuclei.\
Data are presented as mean + SD.](nihms947898f2){#F2}

![Differentiation of C2C12 Cells after KD of *Cry1* and *Cry2*\
(A) MHC staining of C2C12 KD cells during differentiation. Two shRNA clones each were used for *Cry1* and *Cry2* KD. Scale bar, 100 μm.\
(B) Differentiation index on day 5, obtained from the observation of 1,000 nuclei.\
(C) Relative expression levels of five muscle genes determined by qPCR on day 5. The value obtained with control cells was defined as 1.0.\
(D and E) Fusion index (D) and \< 3 nuclei index (E) of KD cells on day 5, obtained from the observation of 1,000 nuclei.\
(F) Relative nuclear number of KD cells on day 5. The number of control nuclei was defined as 1.0. The results were calculated by counting nuclei in four different fields with a 20× lens.\
(G) Temporal profile of the frequency of EdU(+) nuclei in KD cells after induction of differentiation. The results were obtained by counting 1,000 nuclei.\
Data are presented as mean + or ± SD.](nihms947898f3){#F3}

![Gene Expression Analyses of KD C2C12 Cells\
(A) Venn diagrams displaying the number of genes whose expression levels were \> 200% or \< 50% of those of control cells. shRNA clone 1 was used for *Cry1* and *Cry2* KD.\
(B) qPCR results comparing the expression levels of *Ccnd1* during differentiation of KD cells. The value obtained with the control on day 0 was defined as 1.0.\
(C) Temporal profiles of the indicated gene levels in the TA muscles of KO mice. WT expression values at ZT2 on the first day in the graph were defined as 1.0. The light was on between ZT0 and ZT12.\
(D) Temporal profiles of indicated gene levels in undifferentiated KD cells after synchronization with forskolin between −1 and 0 hr. The control value at 24 hr was defined as 1.0. shRNA clone 1 was used for *Cry1* and *Cry2* KD. Cell harvest was initiated 24 hr after forskolin treatment to wait for recovery from its acute effects.\
(E) Temporal profile of EdU uptake in undifferentiated and synchronized C2C12 cells. The results were obtained by counting 1,000 nuclei.\
(F) Temporal profiles of the indicated gene levels in differentiating KD cells after synchronization with forskolin between −1 and 0 hr. The control value at 24 hr was defined as 1.0 for each gene.\
(G) Temporal profile of EdU uptake during differentiation of synchronized KD cells.\
(H) Relative nuclear number of KD cells 120 hr after differentiation. The number in control cells was defined as 1.0.\
Data are presented as mean + or ± SD.](nihms947898f4){#F4}

![Inhibition of Cell Fusion with *Tmem176b* KD in C2C12 Cells\
(A) qPCR comparing the expression levels of *Tmem176b* during differentiation of *Cry1* and *Cry2* KD cells. Two shRNA clones were used for each gene. The expression level of *Tmem176b* in day 0 control cells was defined as 1.0.\
(B) Temporal profiles of *Tmem176b* expression levels in WT, *Cry1*^−/−^, and *Cry2*^−/−^ TA muscles.\
(C) Temporal profiles of *Tmem176b* expression levels in C2C12 cells synchronized with forskolin between −1 and 0 hr and induced to differentiate at 0 hr. shRNA clone 1 was used for Cry1 and Cry2 KD.\
(D) MHC staining of *Tmem176b* KD cells on differentiation day 5. Scale bar, 100 μm.\
(E--G) Differentiation index (E), fusion index (F), and \< 3 nuclei index (G) of *Tmem176b* KD cells on day 5.\
(H) Frequency of nuclei in MHC(+) cells containing 1, 2, 3--5, 6--10, and more than 10 nuclei within one cell during differentiation. A total of 1,000 nuclei were counted at each time point.\
Data are presented as mean + or ± SD.](nihms947898f5){#F5}

![Regulation of *Ccnd1* and *Tmem176b* by Bclaf1\
(A) Silver staining of a gel loaded with immunoprecipitated proteins from FLAG-Cry1- and FLAG-Cry2-expressing undifferentiated cells using an anti-FLAG antibody.\
(B) Western blotting of immunoprecipitated proteins with an anti-FLAG antibody from FLAG-Cry1-expressing (top) and FLAG-Cry2-expressing (bottom) cells. Proteins were detected by the indicated antibodies.\
(C) Western blotting of immunoprecipitated endogenous proteins with anti-Cry1, anti-Cry2, and anti-Bclaf1 antibodies from differentiation day 3 cells.\
(D) Temporal profile of *Bclaf1* expression levels in TA muscles.\
(E--G) Temporal profiles of expression levels of *Bclaf1* (E) and *Ccnd1* (F) and uptake of EdU (G) in KD cells during differentiation. shRNA clone 1 was used for *Cry1*, *Cry2*, and *Bclaf1* KD cells.\
(H) Nuclear number in *Bclaf1* KD cells on day 5.\
(I) Temporal profiles of expression levels of *Tmem176b* in *Bclaf1* KD cells during differentiation.\
(J) MHC staining of *Bclaf1* KD cells on day 5. Scale bar, 100 μm.\
(K--M) Differentiation index (K), fusion index (L), and \< 3 nuclei index (M) of *Bclaf1* KD cells on day 5.\
Data are presented as mean + or ± SD.](nihms947898f6){#F6}

![Stabilization of *Ccnd1* and *Tmem176b* mRNAs by Bclaf1\
(A) Western blotting of immunoprecipitated Bclaf1 from differentiation day 3 cells.\
(B) Relative expression levels of mRNAs in co-immunoprecipitated material with a Bclaf1 antibody. Results with and without reverse transcription are shown. Two PCR primer sets were used for *Ccnd1*, *Ccnd2*, and *Tmem176b*.\
(C and D) Relative expression levels of three mRNAs in *Bclaf1* KD (C) and *Cry2* KD (D) cells treated with actinomycin D. The expression levels were normalized against *Ctla2a* mRNA at each time point and subsequently against 0 hr for each gene.\
(E) Relative expression levels of mRNAs in co-immunoprecipitated material with a Bclaf1 antibody from *Cry2* KD cells on day 3.\
Data are presented as mean + or ± SD.](nihms947898f7){#F7}

###### Highlights

-   Circadian regulator Cry2 promotes muscle cell differentiation and regeneration

-   Cry2-Bclaf1 controls circadian DNA synthesis via cyclin D1 mRNA stabilization

-   Cry2-Bclaf1 promotes circadian myocyte fusion by stabilizing Tmem176b mRNA

-   Bclaf1 depletion recapitulates Cry2 depletion phenotypes in muscle differentiation
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